Nature Medicine

, том 26 , издание 9 , страницы 1422-1427

Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein

Seth J. Zost ¹

Pavlo Gilchuk ¹

Rita E. Chen ^{2, 3}

James Brett Case ³

Joseph X Reidy ¹

Andrew Trivette ¹

Rachel S. Nargi ¹

Rachel E. Sutton ¹

Naveenchandra Suryadevara ¹

Elaine C. Chen ⁴

Elad Binshtein ¹

Swathi Shrihari ³

Mario Ostrowski ⁵

Helen Y. Chu ⁶

Jonathan E. Didier ⁷

Keith W MacRenaris ⁷

Taylor Jones ¹

Samuel Day ¹

Luke Myers ¹

F. Eun-Hyung Lee ⁸

Doan C. Nguyen ⁸

Ignacio Sanz ⁸

David R. Martinez ⁹

Paul W Rothlauf ^{10, 11}

Louis Marie Bloyet ¹¹

Sean Whelan ^{10, 11}

Ralph S Baric ⁹

Larissa B Thackray ³

Michael S. Diamond ^{2, 3, 11, 12}

Robert H. Carnahan ^{1, 13}

James Crowe ^{1, 4, 13}

Скрыть аффилиации авторов Показать аффилиации авторов: 13 аффилиаций

Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, USA |

Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, USA |

Department of Medicine, Washington University School of Medicine, St. Louis, USA |

⁴

Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, USA |

⁵

Department of Medicine, University of Toronto, Toronto, CANADA |

⁶

Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA |

⁷

Berkeley Lights, Inc., Emeryville, USA |

⁸

Department of Medicine, Emory University, Atlanta, USA |

⁹

Department of Epidemiology, University of North Carolina At Chapel Hill, Chapel Hill, USA |

¹⁰

Program in Virology, Harvard Medical School, Boston, USA |

¹¹

Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, USA |

¹²

Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, USA |

¹³

Department of Pediatrics, Vanderbilt University Medical Center, Nashville, USA |

Тип публикации: Journal Article

Дата публикации: 2020-07-10

Springer Nature

Nature Medicine

scimago Q1

wos Q1

БС1

SJR: 18.333

CiteScore: 82.4

Impact factor: 50.0

ISSN: 10788956, 1546170X, 17447933

DOI: 10.1038/s41591-020-0998-x

Скопировать DOI

PubMed ID: 32651581

General Biochemistry, Genetics and Molecular Biology

General Medicine

Краткое описание

Antibodies are a principal determinant of immunity for most RNA viruses and have promise to reduce infection or disease during major epidemics. The novel coronavirus SARS-CoV-2 has caused a global pandemic with millions of infections and hundreds of thousands of deaths to date1,2. In response, we used a rapid antibody discovery platform to isolate hundreds of human monoclonal antibodies (mAbs) against the SARS-CoV-2 spike (S) protein. We stratify these mAbs into five major classes on the basis of their reactivity to subdomains of S protein as well as their cross-reactivity to SARS-CoV. Many of these mAbs inhibit infection of authentic SARS-CoV-2 virus, with most neutralizing mAbs recognizing the receptor-binding domain (RBD) of S. This work defines sites of vulnerability on SARS-CoV-2 S and demonstrates the speed and robustness of advanced antibody discovery platforms. A platform for rapid antibody discovery enabled the isolation of hundreds of human monoclonal antibodies against SARS-CoV-2 and the prioritization of potent antibody candidates for clinical trials in patients with COVID-19.

Найдено

2 цитирования

Юсубалиева Гаухар

🥼 🤝

к.м.н.

84 публикации, 930 цитирований

Индекс Хирша: 16

Институт молекулярной биологии им. В.А. Энгельгардта РАН

Федеральный центр мозга и нейротехнологий ФМБА России

Федеральный научно-клинический центр специализированных видов медицинской помощи и медицинских технологий ФМБА России

Области научных интересов

Иммунотерапия

Клетки CAR-NK

Онколитические вирусы

Стволовые клетки мозга

Экспериментальная онкология

1 цитирование

Иванов Александр

д.б.н.

143 публикации, 3 066 цитирований, 13 рецензий

Индекс Хирша: 25

Институт молекулярной биологии им. В.А. Энгельгардта РАН

Области научных интересов

Активные формы кислорода

ВИЧ

1 цитирование

Локхарт Стивен

26 публикаций, 19 390 цитирований, 4 рецензии

Индекс Хирша: 17

Топ-30

Журналы

	5 10 15 20 25 30 35 40
bioRxiv	bioRxiv, 39, 8.55% bioRxiv 39 публикаций, 8.55%
Cell Reports	Cell Reports, 23, 5.04% Cell Reports 23 публикации, 5.04%
Frontiers in Immunology	Frontiers in Immunology, 14, 3.07% Frontiers in Immunology 14 публикаций, 3.07%
Cell	Cell, 11, 2.41% Cell 11 публикаций, 2.41%
Nature Communications	Nature Communications, 10, 2.19% Nature Communications 10 публикаций, 2.19%
Immunity	Immunity, 10, 2.19% Immunity 10 публикаций, 2.19%
Nature	Nature, 9, 1.97% Nature 9 публикаций, 1.97%
iScience	iScience, 9, 1.97% iScience 9 публикаций, 1.97%
Cell Host and Microbe	Cell Host and Microbe, 7, 1.54% Cell Host and Microbe 7 публикаций, 1.54%
Science	Science, 6, 1.32% Science 6 публикаций, 1.32%
medRxiv : the preprint server for health sciences	medRxiv : the preprint server for health sciences, 6, 1.32% medRxiv : the preprint server for health sciences 6 публикаций, 1.32%
Journal of Clinical Investigation	Journal of Clinical Investigation, 5, 1.1% Journal of Clinical Investigation 5 публикаций, 1.1%
Viruses	Viruses, 5, 1.1% Viruses 5 публикаций, 1.1%
Vaccines	Vaccines, 5, 1.1% Vaccines 5 публикаций, 1.1%
mAbs	mAbs, 5, 1.1% mAbs 5 публикаций, 1.1%
Science Translational Medicine	Science Translational Medicine, 4, 0.88% Science Translational Medicine 4 публикации, 0.88%
Communications Biology	Communications Biology, 4, 0.88% Communications Biology 4 публикации, 0.88%
Signal Transduction and Targeted Therapy	Signal Transduction and Targeted Therapy, 4, 0.88% Signal Transduction and Targeted Therapy 4 публикации, 0.88%
Scientific Reports	Scientific Reports, 3, 0.66% Scientific Reports 3 публикации, 0.66%
International Journal of Molecular Sciences	International Journal of Molecular Sciences, 3, 0.66% International Journal of Molecular Sciences 3 публикации, 0.66%
Frontiers in Microbiology	Frontiers in Microbiology, 3, 0.66% Frontiers in Microbiology 3 публикации, 0.66%
Journal of Biomedical Science	Journal of Biomedical Science, 3, 0.66% Journal of Biomedical Science 3 публикации, 0.66%
PLoS Pathogens	PLoS Pathogens, 3, 0.66% PLoS Pathogens 3 публикации, 0.66%
PLoS ONE	PLoS ONE, 3, 0.66% PLoS ONE 3 публикации, 0.66%
Journal of Virology	Journal of Virology, 3, 0.66% Journal of Virology 3 публикации, 0.66%
Proceedings of the National Academy of Sciences of the United States of America	Proceedings of the National Academy of Sciences of the United States of America, 3, 0.66% Proceedings of the National Academy of Sciences of the United States of America 3 публикации, 0.66%
Journal of Experimental Medicine	Journal of Experimental Medicine, 3, 0.66% Journal of Experimental Medicine 3 публикации, 0.66%
Biomedicines	Biomedicines, 2, 0.44% Biomedicines 2 публикации, 0.44%
Pharmaceutics	Pharmaceutics, 2, 0.44% Pharmaceutics 2 публикации, 0.44%
	5 10 15 20 25 30 35 40

Издатели

	20 40 60 80 100 120
Cold Spring Harbor Laboratory	Cold Spring Harbor Laboratory, 109, 23.9% Cold Spring Harbor Laboratory 109 публикаций, 23.9%
Elsevier	Elsevier, 107, 23.46% Elsevier 107 публикаций, 23.46%
Springer Nature	Springer Nature, 73, 16.01% Springer Nature 73 публикации, 16.01%
MDPI	MDPI, 25, 5.48% MDPI 25 публикаций, 5.48%
Frontiers Media S.A.	Frontiers Media S.A., 24, 5.26% Frontiers Media S.A. 24 публикации, 5.26%
American Association for the Advancement of Science (AAAS)	American Association for the Advancement of Science (AAAS), 14, 3.07% American Association for the Advancement of Science (AAAS) 14 публикаций, 3.07%
Wiley	Wiley, 14, 3.07% Wiley 14 публикаций, 3.07%
Taylor & Francis	Taylor & Francis, 11, 2.41% Taylor & Francis 11 публикаций, 2.41%
Oxford University Press	Oxford University Press, 11, 2.41% Oxford University Press 11 публикаций, 2.41%
Public Library of Science (PLoS)	Public Library of Science (PLoS), 10, 2.19% Public Library of Science (PLoS) 10 публикаций, 2.19%
American Chemical Society (ACS)	American Chemical Society (ACS), 8, 1.75% American Chemical Society (ACS) 8 публикаций, 1.75%
American Society for Microbiology	American Society for Microbiology, 8, 1.75% American Society for Microbiology 8 публикаций, 1.75%
American Society for Clinical Investigation	American Society for Clinical Investigation, 6, 1.32% American Society for Clinical Investigation 6 публикаций, 1.32%
Mary Ann Liebert	Mary Ann Liebert, 4, 0.88% Mary Ann Liebert 4 публикации, 0.88%
Royal Society of Chemistry (RSC)	Royal Society of Chemistry (RSC), 3, 0.66% Royal Society of Chemistry (RSC) 3 публикации, 0.66%
Proceedings of the National Academy of Sciences (PNAS)	Proceedings of the National Academy of Sciences (PNAS), 3, 0.66% Proceedings of the National Academy of Sciences (PNAS) 3 публикации, 0.66%
Rockefeller University Press	Rockefeller University Press, 3, 0.66% Rockefeller University Press 3 публикации, 0.66%
Annual Reviews	Annual Reviews, 3, 0.66% Annual Reviews 3 публикации, 0.66%
Ovid Technologies (Wolters Kluwer Health)	Ovid Technologies (Wolters Kluwer Health), 2, 0.44% Ovid Technologies (Wolters Kluwer Health) 2 публикации, 0.44%
The American Association of Immunologists	The American Association of Immunologists, 1, 0.22% The American Association of Immunologists 1 публикация, 0.22%
Massachusetts Medical Society	Massachusetts Medical Society, 1, 0.22% Massachusetts Medical Society 1 публикация, 0.22%
Social Science Electronic Publishing	Social Science Electronic Publishing, 1, 0.22% Social Science Electronic Publishing 1 публикация, 0.22%
European Molecular Biology Organization	European Molecular Biology Organization, 1, 0.22% European Molecular Biology Organization 1 публикация, 0.22%
Institute of Electrical and Electronics Engineers (IEEE)	Institute of Electrical and Electronics Engineers (IEEE), 1, 0.22% Institute of Electrical and Electronics Engineers (IEEE) 1 публикация, 0.22%
eLife Sciences Publications	eLife Sciences Publications, 1, 0.22% eLife Sciences Publications 1 публикация, 0.22%
Pleiades Publishing	Pleiades Publishing, 1, 0.22% Pleiades Publishing 1 публикация, 0.22%
Mediar Press	Mediar Press, 1, 0.22% Mediar Press 1 публикация, 0.22%
AME Publishing Company	AME Publishing Company, 1, 0.22% AME Publishing Company 1 публикация, 0.22%
Microbiology Society	Microbiology Society, 1, 0.22% Microbiology Society 1 публикация, 0.22%
	20 40 60 80 100 120

Мы не учитываем публикации, у которых нет DOI.
Статистика публикаций обновляется еженедельно.

Вы ученый?

Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.

Войти с ORCID

Метрики

457

Цитировать

ГОСТ |

Цитировать

ГОСТ Скопировать

Zost S. J. et al. Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein // Nature Medicine. 2020. Vol. 26. No. 9. pp. 1422-1427.

ГОСТ со всеми авторами (до 50) Скопировать

Zost S. J., Gilchuk P., Chen R. E., Case J. B., Reidy J. X., Trivette A., Nargi R. S., Sutton R. E., Suryadevara N., Chen E. C., Binshtein E., Shrihari S., Ostrowski M., Chu H. Y., Didier J. E., MacRenaris K. W., Jones T., Day S., Myers L., Lee F. E., Nguyen D. C., Sanz I., Martinez D. R., Rothlauf P. W., Bloyet L. M., Whelan S., Baric R. S., Thackray L. B., Diamond M., Carnahan R. H., Crowe J. Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein // Nature Medicine. 2020. Vol. 26. No. 9. pp. 1422-1427.

RIS |

Цитировать

RIS Скопировать

TY - JOUR

DO - 10.1038/s41591-020-0998-x

UR - https://doi.org/10.1038/s41591-020-0998-x

TI - Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein

T2 - Nature Medicine

AU - Zost, Seth J.

AU - Gilchuk, Pavlo

AU - Chen, Rita E.

AU - Case, James Brett

AU - Reidy, Joseph X

AU - Trivette, Andrew

AU - Nargi, Rachel S.

AU - Sutton, Rachel E.

AU - Suryadevara, Naveenchandra

AU - Chen, Elaine C.

AU - Binshtein, Elad

AU - Shrihari, Swathi

AU - Ostrowski, Mario

AU - Chu, Helen Y.

AU - Didier, Jonathan E.

AU - MacRenaris, Keith W

AU - Jones, Taylor

AU - Day, Samuel

AU - Myers, Luke

AU - Lee, F. Eun-Hyung

AU - Nguyen, Doan C.

AU - Sanz, Ignacio

AU - Martinez, David R.

AU - Rothlauf, Paul W

AU - Bloyet, Louis Marie

AU - Whelan, Sean

AU - Baric, Ralph S

AU - Thackray, Larissa B

AU - Diamond, Michael S.

AU - Carnahan, Robert H.

AU - Crowe, James

PY - 2020

DA - 2020/07/10

PB - Springer Nature

SP - 1422-1427

IS - 9

VL - 26

PMID - 32651581

SN - 1078-8956

SN - 1546-170X

SN - 1744-7933

ER -

BibTex |

Цитировать

BibTex (до 50 авторов) Скопировать

@article{2020_Zost,

author = {Seth J. Zost and Pavlo Gilchuk and Rita E. Chen and James Brett Case and Joseph X Reidy and Andrew Trivette and Rachel S. Nargi and Rachel E. Sutton and Naveenchandra Suryadevara and Elaine C. Chen and Elad Binshtein and Swathi Shrihari and Mario Ostrowski and Helen Y. Chu and Jonathan E. Didier and Keith W MacRenaris and Taylor Jones and Samuel Day and Luke Myers and F. Eun-Hyung Lee and Doan C. Nguyen and Ignacio Sanz and David R. Martinez and Paul W Rothlauf and Louis Marie Bloyet and Sean Whelan and Ralph S Baric and Larissa B Thackray and Michael S. Diamond and Robert H. Carnahan and James Crowe},

title = {Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein},

journal = {Nature Medicine},

year = {2020},

volume = {26},

publisher = {Springer Nature},

month = {jul},

url = {https://doi.org/10.1038/s41591-020-0998-x},

number = {9},

pages = {1422--1427},

doi = {10.1038/s41591-020-0998-x}

}

MLA

Цитировать

MLA Скопировать

Zost, Seth J., et al. “Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein.” Nature Medicine, vol. 26, no. 9, Jul. 2020, pp. 1422-1427. https://doi.org/10.1038/s41591-020-0998-x.

Издатель

Springer Nature

Журнал

Nature Medicine

scimago Q1

wos Q1

БС1

SJR

18.333

CiteScore

82.4

Impact factor

50.0

ISSN

10788956 (Print)

1546170X (Electronic)

17447933 (Electronic)